Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Rotondi

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Endocrinology|May 2, 2022
Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines SecretionFrancesca Coperchini, Alessia Greco, Laura Croce, et al.
Frontiers in Endocrinology|July 31, 2023
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitationLaura Croce, Elisabetta Zampogna, Francesca Coperchini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 12, 2026
Thyroid function and non-alcoholic fatty liver disease in children and adolescent with obesity: a systematic review and meta-analysisElisa Gatta, Massimiliano Ugoccioni, Elena Gandossi, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 20, 2022
A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidismMario Rotondi, Giulia Bendotti, Laura Croce, et al.
European Journal of Endocrinology|April 29, 2006
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory processAlessandro Antonelli, Poupak Fallahi, Mario Rotondi, et al.
Clinical Endocrinology|January 25, 2006
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapyAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Oncotarget|November 20, 2019
The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytesFrancesca Coperchini, Laura Croce, Marco Denegri, et al.
Frontiers in Surgery|May 7, 2026
Double pyramidal lobe detected at ultrasound: a case report with review of the literatureSpyridon Chytiris, Marsida Teliti, Laura Croce, et al.
BMC Cancer|May 13, 2015
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progressionPaola Leporati, Rodolfo Fonte, Luca de Martinis, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidismAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Endocrinology|May 2, 2022
Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines SecretionFrancesca Coperchini, Alessia Greco, Laura Croce, et al.
Frontiers in Endocrinology|July 31, 2023
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitationLaura Croce, Elisabetta Zampogna, Francesca Coperchini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 12, 2026
Thyroid function and non-alcoholic fatty liver disease in children and adolescent with obesity: a systematic review and meta-analysisElisa Gatta, Massimiliano Ugoccioni, Elena Gandossi, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 20, 2022
A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidismMario Rotondi, Giulia Bendotti, Laura Croce, et al.
European Journal of Endocrinology|April 29, 2006
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory processAlessandro Antonelli, Poupak Fallahi, Mario Rotondi, et al.
Clinical Endocrinology|January 25, 2006
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapyAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Oncotarget|November 20, 2019
The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytesFrancesca Coperchini, Laura Croce, Marco Denegri, et al.
Frontiers in Surgery|May 7, 2026
Double pyramidal lobe detected at ultrasound: a case report with review of the literatureSpyridon Chytiris, Marsida Teliti, Laura Croce, et al.
BMC Cancer|May 13, 2015
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progressionPaola Leporati, Rodolfo Fonte, Luca de Martinis, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidismAlessandro Antonelli, Mario Rotondi, Poupak Fallahi, et al.
Pageof 21